NCT00479388
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
See it on ClinicalTrials.gov ↗1,216 people
48.8%
51.2%
593 womenmiddle line = equal numbers623 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 2008-10
- Health conditions
- Primary Hypercholesterolemia, Mixed Dyslipidemia
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 60.5 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.